regrelor
... that regrelor , a new experimental antiplatelet drug, was withdrawn during a phase II clinical trial due to an increased risk of bleeding?
... that <b id="mwATI"><a href="./Regrelor" id="mwATM" rel="mw:WikiLink" title="Regrelor">regrelor</a></b> <i id="mwATQ">(pictured)</i>, a new experimental <a href="./Antiplatelet_drug" id="mwATU" rel="mw:WikiLink" title="Antiplatelet drug">antiplatelet drug</a>, was withdrawn during a phase II <a href="./Clinical_trial" id="mwATY" rel="mw:WikiLink" title="Clinical trial">clinical trial</a> due to an increased risk of bleeding?